article thumbnail

Governor Cuomo Announces the New York State Department of Health’s Cannabinoid Hemp Program Now Accepting License Applications – Cannabis Business Executive

SpeedWeed

“This exciting opportunity to be a part of the state’s regulated Cannabinoid Hemp Program is great news for farmers and consumers.”. In accordance with legislation signed last year by the Governor, the Department has created a Cannabinoid Hemp Program.

article thumbnail

OregonCBD Uses Intelligent Breeding and DNA-Based Tools to Disrupt Hemp Extract Market

Medicinal Genomics

The published sociologist-turned cannabis breeder entered the industrial hemp market in 2015, partnering with his brother Eric. The development of Type IV cultivars will allow for a far more specialized cannabinoid market, opening the door to immense breeding potentials to create highly varied chemoprofiles.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Devonian Health Group Announces Cannabis Cutting-Edge Extraction Equipment in Its Montmagny Facility

Cannabis Law Report

This agreement includes the installation of state-of-the-art ethanol extraction equipment in Devonian’s facility in Montmagny (Quebec) for the purpose of extracting cannabinoids from hemp and cannabis plant. Both parties expect to collaborate in the development of cannabinoid-based botanical drugs.

article thumbnail

Understanding Full Spectrum CBD Oil and Why It Is Important

Cannabis Cheri

Cannabidiol (or CBD) is one of the hundreds of different cannabinoids found in the Cannabis sativa plant. This non-psychoactive (meaning it doesn’t make you high) cannabinoid has been all the rage over the last couple of years. Moreover, type 1 cannabinoid receptors also play a role in warding off anxiety.

Oil 222
article thumbnail

MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF

Cannabis Law Report

TSX: LABS) (OTCQX: MEDIF ) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a US FDA DMF for pure natural CBD API. MediPharm Labs Corp. These projects will all require pharmaceutical approved API if commercialized. Additional Information.

article thumbnail

Mary AG Now Has Room to Grow Hemp in China Through CBDer Partnership

Cannabis Law Report

Mary AG’s joint venture Yunnan Moquan and CBDer are currently the only companies licensed for indoor industrial hemp cultivation in China’s only legalized province for cannabinoid extraction. The partner also is compliant with ISO9001:2015, ISO14001:2015, OHSAS18001:2011 to meet high international quality standards.

Hemp 105
article thumbnail

Cannabis and Novel Food Authorizations in the EU: Q&A

Canna Law Blog

Novel foods are regulated in the European Union by the so-called Novel Food Regulation (Regulation (EU) 2015/2283). In January 2019, the catalog was amended to classify extracts from industrial hemp containing cannabinoids as a novel food. His answers are a must-read for cannabis food businesses interested in the EU market.

Food 86